摘要
1例ST段抬高型心肌梗死患者入院时血小板水平偏低,冠状动脉旁路移植术后使用双联抗血小板药物加肝素类药物预防血栓形成,在治疗期间多次出现较严重的出血,并有多发动静脉血栓形成。临床药师结合诊疗经过,对出血与血栓并存可能原因进行分析,对该患者出血风险与血栓形成风险进行评估,并对下一步抗血栓方案提出建议。
A patient with ST-segment elevation myocardial infarction had low platelet levels on admission and was treated with dual antiplatelet drugs and heparin to prevent thrombosis after coronary artery bypass grafting.During the treatment,severe bleeding occurred many times and multiple arterial and venous thrombosis developed.Based on the process of treatment,the clinical pharmacist analyzed the possible causes of coexistence of bleeding and thrombosis,evaluated the risk of bleeding and thrombosis for the patient,and put forward suggestions for the next anti-thrombosis program.
作者
花曼祺
刘志艳
向倩
HUA Man qi;LIU Zhi-yan;XIANG Qian(Department of Pharmacy,Peking University First Hospital,Beijing 100034,China;Department ofPharmacy Administration and Clinical Pharmacy,School ofPharmaceutical Sciences,Peking University,Bejing 100191,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2023年第12期1795-1797,共3页
The Chinese Journal of Clinical Pharmacology
关键词
ST段抬高型心肌梗死
出血与血栓并存
抗凝
抗血小板
ST segment elevation myocardial infarction
coexistence of bleeding and thrombosis
anticoagulation
antiplatelet
